Cargando…
Effect of Intratrigonal Botulinum Toxin in Patients with Bladder Pain Syndrome/Interstitial Cystitis: A Long-Term, Single-Center Study in Real-Life Conditions
The high percentage of treatment failures seen in patients with bladder pain syndrome/interstitial cystitis (BPS/IC) managed conservatively frequently demands invasive treatment options. We aimed to evaluate the long-term efficacy and adverse events of intratrigonal botulinum toxin injection in such...
Autores principales: | Abreu-Mendes, Pedro, Ferrão-Mendes, António, Botelho, Francisco, Cruz, Francisco, Pinto, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692970/ https://www.ncbi.nlm.nih.gov/pubmed/36356025 http://dx.doi.org/10.3390/toxins14110775 |
Ejemplares similares
-
Botulinum Toxin A for Bladder Pain Syndrome/Interstitial Cystitis
por: Chiu, Bin, et al.
Publicado: (2016) -
Silodosin Improves Pain and Urinary Frequency in Bladder Pain Syndrome/Interstitial Cystitis Patients
por: Abreu-Mendes, Pedro, et al.
Publicado: (2022) -
Daily low dose of tadalafil improves pain and frequency in bladder pain syndrome/interstitial cystitis patients
por: Abreu-Mendes, Pedro, et al.
Publicado: (2022) -
Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis
por: Chen, Jing-Liang, et al.
Publicado: (2020) -
The clinical application of intravesical botulinum toxin A injection in patients with overactive bladder and interstitial cystitis
por: Jiang, Yuan-Hong, et al.
Publicado: (2022)